Henn Matthew R Insider Trading Activity

Also formerly known as Henn Matthew R.
Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$2.5M

Insider Activity of Henn Matthew R

According to the SEC Form 4 filings, Henn Matthew R, being in a position of

  1. See Remarks at Seres Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1504 shares for $23,448,
    over all time since 2020-12-01, has bought 0 shares, and sold 112200 shares for $2.53M.

Biography of Henn Matthew R

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$23,4484100

Comparison of Insiders on Amount of Buys and Sells

2026-08-17SaleSeres Therapeutics, Inc.
MCRB
See Remarks
81
0.0008%
$4.55$369-21.95%
2026-05-18SaleSeres Therapeutics, Inc.
MCRB
See Remarks
77
0.0008%
$7.53$580-34.12%
2026-02-15SaleSeres Therapeutics, Inc.
MCRB
See Remarks
89
0.001%
$8.47$754-20.29%
2025-11-15SaleSeres Therapeutics, Inc.
MCRB
See Remarks
1,257
0.0149%
$17.30$21,746-64.28%
2025-08-18SaleSeres Therapeutics, Inc.
MCRB
See Remarks
73
0.0008%
$16.65$1,215-47.31%
2025-05-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
77
0.0009%
$7.28$561+91.62%
2025-02-18SaleSeres Therapeutics, Inc.
MCRB
See Remarks
3,953
0.0023%
$0.81$3,204-10.35%
2024-11-18SaleSeres Therapeutics, Inc.
MCRB
See Remarks
927
0.0005%
$0.54$501+32.3%
2024-10-28SaleSeres Therapeutics, Inc.
MCRB
See Remarks
3,984
0.0021%
$0.69$2,749+9.25%
2024-08-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
923
0.0006%
$0.84$775-14.77%
2024-05-15SaleSeres Therapeutics, Inc.
MCRB
See Remarks
891
0.0006%
$0.94$838-14.74%
2024-02-16SaleSeres Therapeutics, Inc.
MCRB
See Remarks
4,170
0.0033%
$1.08$4,504-19.19%
2023-10-30SaleSeres Therapeutics, Inc.
MCRB
See Remarks
3,886
0.0028%
$1.35$5,246-31.83%
2020-12-01SaleSeres Therapeutics, Inc.
MCRB
See Remarks
91,812
0.1181%
$27.04$2.48M-22.88%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.